The Recurrence Reality

Major depressive disorder is a recurrent condition for the majority of people who experience it, and understanding this reality is essential for making informed decisions about treatment duration. The epidemiological data are clear and consistent: after a first depressive episode, approximately 50% of people will experience a second. After a second episode, the risk of a third rises to approximately 70%. After three or more episodes, the risk of future recurrence exceeds 90% — making continuation of treatment not a matter of preference but of medical risk management.

Each recurrence carries additional risk beyond simply experiencing another episode. The phenomenon of “kindling” in mood disorders describes the observation that each subsequent depressive episode is triggered more easily than the previous one — requiring less severe precipitating stress to initiate — and is harder to treat to full remission. The threshold for an episode to occur decreases with each recurrence, and the treatment response for later episodes is sometimes attenuated. This is not inevitable with appropriate maintenance treatment, but it is the natural history without it.

Risk factors that identify individuals at highest risk for recurrence include: onset of depression before age 20; three or more prior episodes; incomplete remission from the current episode (residual symptoms, even mild ones, significantly increase recurrence risk); long duration of episodes before treatment; comorbid anxiety disorder (which roughly doubles recurrence risk); chronic medical illness; chronic stress or high-conflict relationships; inadequate maintenance treatment after remission; and personal and family history of the specific recurrence patterns seen in their family. Identifying your personal risk profile is a useful exercise that most people do not undertake because they assume that once they feel better, the episode is behind them. Understanding that the episode may be behind them while the risk remains is the key conceptual shift.

The good news is that recurrence is substantially preventable. Maintenance medication reduces recurrence risk by 50–70% compared to placebo in most well-designed studies — a larger effect than most medications produce for any physical health condition. Continuation-phase psychotherapy, particularly mindfulness-based cognitive therapy (MBCT), produces meaningful additional relapse prevention benefit over and above medication effects. And active monitoring for prodromal signs — the early warning signs that a new episode is beginning — allows intervention before a partial slide becomes a full episode.

What Maintenance Treatment Involves

Maintenance treatment for depression involves continuing the effective antidepressant at the dose that produced remission for a duration determined by the individual’s risk profile — not stepping down the dose once you feel better, which is a common and consequential mistake. The dose that produced remission is the maintenance dose. Reducing the dose to “a maintenance level” before the maintenance period is complete is not standard clinical practice and increases relapse risk.

The recommended duration of maintenance treatment is individualized but generally follows a stepped framework. For a first depressive episode, most guidelines recommend 6–12 months of continued treatment after remission before a provider-guided taper is considered. For a second episode, 2 years or more is typically recommended. After three or more episodes, indefinite continuation is appropriate for many patients given the high recurrence risk. These are general guidelines, not absolute rules; the specific recommendation for any individual depends on episode severity, residual symptoms, other risk factors, and patient preference.

Mindfulness-based cognitive therapy (MBCT) has among the strongest evidence for depression relapse prevention of any psychological intervention. In multiple randomized controlled trials, MBCT reduces the recurrence rate in people with three or more prior depressive episodes by approximately 43% compared to usual care alone. It works by teaching patients to recognize and decouple from the rumination patterns and automatic negative thought patterns that trigger recurrence before they spiral into a full episode. It is most effective as a maintenance-phase intervention during a period of relative wellness, not during an active episode. If your provider recommends MBCT or continuation-phase therapy, this is not because you are still unwell — it is because the preventive work is most effective when done in wellness.

Building a Relapse Prevention Plan

A relapse prevention plan is a structured document you create with your provider during the maintenance phase — when you are well enough to think clearly about it — that serves as a roadmap for early intervention if symptoms begin to return. A good relapse prevention plan includes: your personal early warning signs (the specific symptoms and functional changes that typically occur first when depression is beginning, which differ from person to person — for some it is sleep changes, for others social withdrawal, for others loss of appetite or increased irritability); the situations and stressors most likely to trigger a new episode for you specifically; the actions to take at first warning sign appearance (contact your provider immediately, not “wait and see”); the people who know you well enough to notice warning signs you might be minimizing; and the clinical contacts and resources for rapid response.

The plan is most useful when it is written, specific, and shared with one trusted person in your life who can help monitor for warning signs you might not be seeing yourself. Depression’s cognitive symptoms — hopelessness, negative thinking, difficulty concentrating — impair the person’s ability to accurately assess their own condition during an early slide, which is exactly when clear-headed external perspective is most valuable.

When to Contact Your Provider

Do not wait for a full depressive episode to contact your provider if something is changing. Early intervention during a prodromal period — when you notice the first warning signs but are not yet in a full episode — is significantly more effective than intervention after a full episode has developed. The relationship you have built with your provider during the maintenance phase, the plan you have developed together, and the medication you are already on all work together to make early intervention faster and more targeted than intervention from a cold start.

Contact your provider immediately if: you notice more than one or two of your personal warning signs; your functioning is declining without an external explanation; you have thoughts of self-harm; or someone who knows you well expresses concern. Call (430) 288-5800″see if it passes.” Early response is the most important element of relapse prevention outside of consistent maintenance treatment.